Development of quinolone-resistant strains of Escherichia coli in stools of patients with cirrhosis undergoing norfloxacin prophylaxis: Clinical consequences

Journal of Hepatology

Volumn 31, Issue 2, 1999, Pages 277-283

  Aparicio, José Ramón ^a   Such, José ^a   Pascual, Sonia ^a   Arroyo, Angeles ^b   Plazas, Joaquín ^b   Girona, Eva ^a   Gutiérrez, Ana ^a   Vera, Félix De ^a   Palazón, José Maria ^a   Carnicer, Fernando ^a   Pérez Mateo, Miguel ^a  

^a Servicio de Medicina Interna   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

Cirrhosis; Escherichia coli; Norfloxacin prophylaxis; Nosocomial bacterial infections; Quinolone resistance

Indexed keywords

NORFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; ESCHERICHIA COLI; FECES ANALYSIS; FEMALE; HIGH RISK POPULATION; HOSPITAL INFECTION; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL;

EID: 0032775851     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80225-6     Document Type: Article

References (28)

1. Caly WR, Strauss E. A prospective study of bacterial infections in patients with cirrhosis. J Hepatol. 18:1993;353-358.
2. Palazon JM, Garcia A, Gomez A. Infecciones hopitalarias en pacientes con cirrosis hepática. Gastroenterol Hepatol. 7:1984;120-122.
3. Rimola A. Infecciones bacterianas en la cirrosis hepática. MTA-Medicina Interna. 5:1987;161-224.
4. Felisart J, Rimola A, Arroyo V, Perez Ayuso RM, Quintero E, Gines P, et al. Cefotaxime is more effective than is ampicillintobramycin in cirrhotics with severe infections. Hepatology. 5:1985;457-462.
5. Guarner C, Runyon BA. Spontaneous bacterial peritonitis: pathogenesis, diagnosis, and management. Gastroenterologist. 3:1995;311-328.
6. Runyon BA. Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis. Gastroenterology. 91:1986;1343-1346.
7. Such J, Guarner C, Enriquez J, Rodriguez JL, Seres I, Vilardell F. Low C3 in cirrhotic ascites predisposes to spontaneous bacterial peritonitis. J Hepatol. 6:1988;80-84.
8. Rimola A, Bory F, Teres J, Perez Ayuso RM, Arroyo V, Rodes J. Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage. Hepatology. 5:1985;463-467.
9. Soriano G, Guarner C, Tomas A, Villanueva C, Torras X, Gonzalez D, et al. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage. Gastroenterology. 103:1992;1267-1272.
10. Ginès P, Rimola A, Planas R, Vargas V, Marco F, Almela M, et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology. 12:1990;716-724.
11. Soriano G, Guarner C, Teixido M, Such J, Barrios J, Enriquez J, et al. Selective intestinal decontamination prevents spontaneous bacterial peritonitis. Gastroenterology. 100:1991;477-481.
12. Bernard B, Grange JD, Nguyen E, Amiot X, Opolon P, Poynard T. Antibiotic prophylaxis (AbP) for the prevention of bacterial infections in cirrhotic patients with ascites: a meta-analysis. [abstract] Hepatology. 24:1996;1271A.
13. Grange JD, Bernard B, Nguyen E, Opolon P, Poynard T. Antibiotic prophylaxis (AbP) for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding (GB): a metaanalysis. [abstract] Hepatology. 24:1996;1272A.
14. Inadomi J, Sonnenberg A. Cost-analysis of prophylactic antibiotics in spontaneous bacterial peritonitis. Gastroenterology. 113:1997;1289-1294.
15. Dupeyron C, Mangeney N, Sedrati L, Campillo B, Fouet P, Leluan G. Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis. Antimicrob Agents Chemother. 38:1994;340-344.
16. Carratalà J, Fernandez-Sevilla A, Tubau F, Dominguez MA, Gudiol F. Emergence of fluorquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis. Antimicrob Agents Chemother. 40:1996;503-505.
17. Castellote J, Xiol J, Rota-Roca R, Fernandez-Esparrach G. Spontaneous bacterial peritonitis and empyema by Escherichia coli resistant to norfloxacine in a patient on selective intestinal decontamination with norfloxacin. J Hepatol. 20:1994;436.
18. Novella M, Sola R, Soriano G, Andreu M, Gana J, Ortiz J, et al. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin. Hepatology. 25:1997;532-536.
19. Baquero F, Martinez-Beltran J, Canton R. Crieria of the MEN-SURA group for the definition of the critical points of sensitivity to antibiotics. Enferm Infecc Microbiol Clin. 16:1998;85-92.
20. Such J, Runyon BA. Spontaneous bacterial peritonitis. Clin Infect Dis. 27:1998;669-676.
21. Grange D, Roulot D, Pelletier G, Pariente EA, Denis J, Ink O, et al. Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial. J Hepatol. 29:1998;430-436.
22. Karp JE, Merz WG, Hendricksen C, Laughon B, Redden T, Bamberger BJ, et al. Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 106:1987;1-7.
23. Tomás A, Soriano G, Guarner C, Portorreal R, Novella MT, Vilardell F. Hospital-acquired bacterial infections in patients with cirrhosis undergoing selective intestinal decontamination. J Hepatol. 18:1993;262-263.
24. Cometta A, Calandra T, Bille J, Glauser MP. Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia. New Engl J Med. 330:1994;1240-1241.
25. Terg R, Llano K, Cobas SM, Brotto C, Barrios A, Levi D, et al. Effects of oral ciprofloxacin on aerobic gram-negative fecal flora in patients with cirrhosis: results of short- and long-term administration, with daily and weekly dosages. J Hepatol. 29:1998;437-442.
26. Rolachon A, Cordier L, Bacq Y, Nousbaum JB, Franza A, Paris JC, et al. Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial. Hepatology. 22:1995;1171-1174.
27. Llovet JM, Rodriguez Iglesias P, Moitinho E, Planas R, Bataller R, Navasa M, et al. Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination. A retrospective study of 229 spontaneous bacterial peritonitis episodes. J Hepatol. 26:1997;88-95.
28. Guarner C, Runyon BA, Young S, Heck M, Sheikh MY. Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. J Hepatol. 26:1997;1372-1378.